OSW Stock Analysis: OneSpaWorld Holdings | NASDAQ
Leisure | NASDAQ, USA | Market Cap: 2.564m USD | 12M Return: 12.1% | BSP736841136 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.2M
EPS Trend: 98.4%
Qual. Beats: 0
Rev. Trend: 99.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 8.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
OneSpaWorld Holdings Limited (OSW) operates health and wellness centers primarily onboard cruise ships and at destination resorts across the United States and internationally. The company provides a broad range of services including massage and body care, aesthetics, medi-spa treatments, acupuncture, fitness and personalized training, nutritional consultation, and hydro-therapies utilizing amenities such as infrared saunas, snow rooms, and cold plunge pools. It also retails branded products from partners including ELEMIS, Grown Alchemist, Kerastase, Keratin Complex, Thermage, Dysport, GoodFeet, Hyperice, and Megawhite teeth whitening. Founded in 2017, OneSpaWorld is headquartered in Nassau, Bahamas, and is classified within the Consumer Discretionary sector under Specialized Consumer Services.
The companys business model is largely B2B2C, generating revenue through long-term concession agreements with major cruise operators while delivering services and products directly to cruise passengers and resort guests. Performance is closely tied to the cruise industrys passenger volumes and onboard spending trends, making it a leveraged play on global leisure travel demand.
- Cruise passenger volumes and onboard spending recovery drive revenue
- New ship fleet additions expand exclusive cruise line partnership contracts
- Destination resort segment growth and margin expansion accelerate
| Net Income: 81.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.60 > 1.0 |
| NWC/Revenue: 10.98% < 20% (prev 7.83%; Δ 3.15% < -1%) |
| CFO/TA 0.13 > 3% & CFO 95.5m > Net Income 81.0m |
| Net Debt (59.7m) to EBITDA (109.6m): 0.55 < 3 |
| Current Ratio: 2.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (102.4m) vs 12m ago -1.87% < -2% |
| Gross Margin: 14.29% > 18% (prev 15.91%; Δ -1.61% > 0.5%) |
| Asset Turnover: 138.1% > 50% (prev 125.6%; Δ 12.52% > 0%) |
| Interest Coverage Ratio: 6.81 > 6 (EBIT TTM 96.7m / Interest Expense TTM 14.2m) |
| A: 0.15 (Total Current Assets 169.1m - Total Current Liabilities 58.2m) / Total Assets 729.8m |
| B: -0.29 (Retained Earnings -208.7m / Total Assets 729.8m) |
| C: 0.13 (EBIT TTM 96.7m / Avg Total Assets 730.8m) |
| D: 3.94 (Book Value of Equity 582.2m / Total Liabilities 147.6m) |
| Altman-Z'' = 5.09 = AAA |
| DSRI: 1.03 (Receivables 53.6m/47.3m, Revenue 1.01b/919.3m) |
| GMI: 1.11 (GM 15.91% / 14.29%) |
| AQI: 0.96 (AQ_t 0.72 / AQ_t-1 0.75) |
| SGI: 1.10 (Revenue 1.01b / 919.3m) |
| TATA: -0.02 (NI 81.0m - CFO 95.5m) / TA 729.8m) |
| Beneish M = -2.85 (Cap -4..+1) = A |
As of September 01, 2026, the stock is trading at USD 24.83 with a total of 1,060,181 shares traded. Over the past week, the price has changed by -6.34%, over one month by -3.43%, over three months by +4.53% and over the past year by +12.07%.
Current recommended Stop Loss: 23.80 (which is 4.1% or 1.3 ATR below the current price).
OneSpaWorld Holdings has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy OSW.
- StrongBuy: 4
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 31.2 | 25.7% |
P/E Trailing = 33.2368
P/E Forward = 27.8552
P/S = 2.5397
P/B = 4.5641
Revenue TTM = 1.01b USD
EBIT TTM = 96.7m USD
EBITDA TTM = 109.6m USD
Long Term Debt = 81.6m USD (from longTermDebt, last quarter)
Short Term Debt = 1.53m USD (from shortTermDebt, last quarter)
Debt = 100.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 9.25m
Net Debt = 59.7m USD (calculated: Debt 100.1m - CCE 40.4m)
Enterprise Value = 2.62b USD (2.56b + Debt 100.1m - CCE 40.4m)
Interest Coverage Ratio = 6.81 (Ebit TTM 96.7m / Interest Expense TTM 14.2m)
EV/FCF = 33.54x (Enterprise Value 2.62b / FCF TTM 78.2m)
FCF Yield = 2.98% (FCF TTM 78.2m / Enterprise Value 2.62b)
FCF Margin = 7.75% (FCF TTM 78.2m / Revenue TTM 1.01b)
Net Margin = 8.02% (Net Income TTM 81.0m / Revenue TTM 1.01b)
Gross Margin = 14.29% ((Revenue TTM 1.01b - Cost of Revenue TTM 865.2m) / Revenue TTM)
Gross Margin QoQ = 15.50% (prev 15.12%)
Tobins Q-Ratio = 3.59 (Enterprise Value 2.62b / Total Assets 729.8m)
Interest Expense / Debt = 14.17% (Interest Expense 14.2m / Debt 100.1m)
Taxrate = 4.57% (3.88m / 84.8m)
NOPAT = 92.3m (EBIT 96.7m * (1 - 4.57%))
Current Ratio = 2.91 (Total Current Assets 169.1m / Total Current Liabilities 58.2m)
Debt / Equity = 0.17 (Debt 100.1m / totalStockholderEquity, last quarter 582.2m)
Debt / EBITDA = 0.55 (Net Debt 59.7m / EBITDA 109.6m)
Debt / FCF = 0.76 (Net Debt 59.7m / FCF TTM 78.2m)
Total Stockholder Equity = 559.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.08% (Net Income 81.0m / Total Assets 729.8m)
RoE = 14.46% (Net Income TTM 81.0m / Total Stockholder Equity 559.8m)
RoCE = 15.07% (EBIT 96.7m / Capital Employed (Equity 559.8m + L.T.Debt 81.6m))
RoIC = 14.58% (NOPAT 92.3m / Invested Capital 632.8m)
WACC = 9.57% (E(2.56b)/V(2.66b) * Re(9.42%) + D(100.1m)/V(2.66b) * Rd(14.17%) * (1-Tc(0.05)))
Discount Rate = 9.42% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.28 | Cagr: -0.23%
[DCF] Terminal Value 74.11% ; FCFF base≈73.6m ; Y1≈84.4m ; Y5≈124.2m
[DCF] Fair Price = 14.56 (EV 1.54b - Net Debt 59.7m = Equity 1.48b / Shares 101.5m; r=9.57% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.37 | EPS CAGR: 22.56% | SUE: 0.0 | # QB: 0
Revenue Correlation: 99.27 | Revenue CAGR: 9.87% | SUE: 0.17 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.30 | Chg30d=-3.69% | Revisions=-57% | Analysts=6
EPS current Year (2026-12-31): EPS=1.14 | Chg30d=+0.15% | Revisions=-17% | GrowthEPS=+14.8% | GrowthRev=+7.6%
EPS next Year (2027-12-31): EPS=1.30 | Chg30d=+0.64% | Revisions=+0% | GrowthEPS=+14.8% | GrowthRev=+8.7%
[Analyst] Revisions Ratio: -36% (up=3, down=8)